CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-03 | Kulkarni Samarth Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +49,500 | 49,500 | ||
| 2025-10-03 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2025-10-03 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2025-10-03 | Prasad Raju Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2025-09-17 | Kulkarni Samarth Chief Executive Officer | Gift | −6,000 | 201,004 | ||
| 2025-08-18 | Kulkarni Samarth Chief Executive Officer | Sale | −13,081 | $58.15 | $761K | 207,004 |
| 2025-08-16 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | 220,085 | ||
| 2025-08-16 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −25,000 | 0 | ||
| 2025-08-06 | Behbahani Ali Director | Other acquisition | +60 | 316 | ||
| 2025-08-06 | Behbahani Ali Director | Other acquisition | +15 | 29 | ||
| 2025-08-06 | Treco Douglas A Director | Purchase | +20,000 | $57.03 | $1.1M | 22,000 |
| 2025-07-16 | George Simeon Director | Purchase | +6,510 | $52.03 | $339K | 69,687 |
| 2025-07-16 | George Simeon Director | Purchase | +22,319 | $52.03 | $1.2M | 238,897 |
| 2025-07-16 | George Simeon Director | Purchase | +960,983 | $52.03 | $50.0M | 1,730,179 |
| 2025-06-05 | George Simeon Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Morrison Briggs Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Treco Douglas A Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Rommel Christian Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Fleming Harold Edward Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 |
Page 7 of 46 · 910 trades